Compare PGEN & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | IHRT |
|---|---|---|
| Founded | 1998 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 589.5M |
| IPO Year | 2013 | 2019 |
| Metric | PGEN | IHRT |
|---|---|---|
| Price | $6.85 | $2.70 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 5 | 2 |
| Target Price | ★ $8.33 | $4.25 |
| AVG Volume (30 Days) | ★ 4.6M | 519.1K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.19 |
| EPS | ★ 0.03 | N/A |
| Revenue | $230,981,000.00 | ★ $3,864,991,000.00 |
| Revenue This Year | $1,115.92 | $9.96 |
| Revenue Next Year | $81.04 | N/A |
| P/E Ratio | $226.67 | ★ N/A |
| Revenue Growth | N/A | ★ 0.27 |
| 52 Week Low | $2.99 | $2.26 |
| 52 Week High | $7.72 | $6.56 |
| Indicator | PGEN | IHRT |
|---|---|---|
| Relative Strength Index (RSI) | 47.73 | 37.89 |
| Support Level | $6.60 | $2.56 |
| Resistance Level | $7.32 | $4.03 |
| Average True Range (ATR) | 0.28 | 0.14 |
| MACD | -0.10 | 0.03 |
| Stochastic Oscillator | 9.36 | 33.15 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.